Mamsakizhi
About Mamsakizhi
Mamsakizhi is one of Ayurveda's most powerfully anabolic bolus therapies — prepared with carefully selected animal protein, medicated decoctions, and rebuilding herbs, then bundled into linen boluses and massaged warm over the affected region. It is reserved for cases where deep tissue rebuilding is the priority: muscle wasting after prolonged illness or surgery, post-stroke paralysis, severe debility, neurological weakness, and conditions involving Mamsa Dhatu Kshaya (depletion of the muscle tissue layer). Where Njavarakizhi is the cornerstone anabolic therapy for most muscle and disc rebuilding, Mamsakizhi is brought in when the rebuilding required is even more intense — typically in patients with significant emaciation, atrophy, or post-paralytic weakness. At Agasthya, Mamsakizhi is prescribed selectively by Dr. T.D. Bose for specific rebuilding indications within longer treatment programmes.
Duration
60–90 minutes per session; typically 14–21 days as part of a treatment protocol
Key Benefits
Indications
- Muscle wasting and atrophy
- Post-stroke hemiplegia and paralysis
- Severe debility and emaciation
- Neurological weakness and motor recovery
- Mamsa Dhatu Kshaya (muscle tissue depletion)
- Post-surgery rehabilitation in weakened patients
- Advanced osteoarthritis with significant muscle wasting
Frequently Asked Questions
How is Mamsakizhi different from Njavarakizhi?
Who is Mamsakizhi prescribed for at Agasthya?
How long is a Mamsakizhi protocol?
Ready to Experience the Benefits?
Book a consultation with our Ayurvedic specialists to learn how Mamsakizhi can help you.
Conditions This Treats
- Marma Chikitsa → The complete guide to our core treatment approach
- Back Pain Treatment → Comprehensive approach to spine, muscle, and rehabilitation conditions
Why Agasthya?
- NABH-certified hospital
- 10,000+ cases treated
- 30+ years of experience
- Led by Dr. T.D. Bose
- 4.9/5 rating (200+ reviews)
Medically reviewed by Dr. T.D. Bose, Chief Physician, Agasthya Ayurvedic Hospital. Last updated: March 22, 2026.